Hemideina has raised funds via a private placement

Hemideina has raised US$7.4 million. The capital raised will be used to fund product development in preparation for the first human studies.

Hemideina is a Melbourne-based private company that is set to disrupt the cochlear implant market through its proprietary mechanical signal processing technology, the Hera wireless implant system. The company aims to provide a paradigm shift in hearing implant performance that will lead to increased access and adoption of treatment.

Oaklins’ team in Australia acted as lead manager in this transaction. The team has assisted Hemideina with fundraising since 2018 and is proud to support them on their mission to positively impact the lives of people with severe-to-profound hearing loss.

Uppdrag

Kapitalanskaffning, finansiering och ECM

Parter

“I’d like to extend my thanks to the team for managing the raise, as well as our team. The high-caliber work completed to date has built confidence around our technology with investors and continues to be the key to our success.”

Elizabeth Williams

CEO and co-founder, Hemideina

Prata med transaktionsteamet

Jonathan Tooth

Director

Melbourne, Australien
Oaklins Henslow

Se profil Kontakta oss

Ryan Whitelegg

Managing Director

Melbourne, Australien
Oaklins Henslow

Se profil Kontakta oss

Relaterade affärer

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

Hälsovård

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth, as well as investing in service quality, innovation and efficiency.

Lär dig mer

PBV Investment Holding Europe-America, S.L. (IDP Group) has been sold to Bureau Veritas

Riskkapital | Bygg- & tekniktjänster

PBV Investment Holding Europe-America, S.L. (IDP Group) has been sold to Bureau Veritas

Nazca Capital and the company founders have sold PBV Investment Holding Europe-America, S.L. (IDP Group) to Bureau Veritas. This strategic acquisition will allow Bureau Veritas to expand its leadership in building and infrastructure solutions and meet sustainability challenges through IDP’s digital portfolio assets.

Lär dig mer

HD Clinical Ltd. has been acquired by NEXUS AG

Hälsovård | TMT

HD Clinical Ltd. has been acquired by NEXUS AG

NEXUS AG has acquired HD Clinical Ltd. Through this acquisition, NEXUS has gained a recognized and internationally active team of experts in structured diagnostic reporting and image processing. This will provide new regional access, strengthening its strong European market position in software, particularly for internal medicine.

Lär dig mer